Renishaw is pleased to announce the launch of the neurolocate™ patient registration system in countries that recognise the CE (Conformité Européene) mark.
neurolocate is a frameless patient registration system for the neuromate® stereotactic robot. The technology is based on a robot arm mounted fiducial marker frame with intraoperative X-Ray/CT.
Prof. Steven Gill, Consultant Neurosurgeon at North Bristol NHS Trust said, “neurolocate is helping us to speed up the surgical workflow while giving us the registration accuracy we need for our stereotactic procedures.”
Dr. Francesco Cardinale, Neurosurgeon at the Claudio Munari Center for Epilepsy at Niguarda Hospital in Milano, Italy added, “neurolocate will provide us with multiple advantages compared to currently available registration systems. As all the planning images are taken well in advance of the procedure, without the need for any fiducials, we will be able to work in frameless mode with the precision of a framebased procedure; fully exploiting the capabilities of intraoperative imaging and eliminating the need to move the patient between the operating room and the CT scanner facility.”
Dr. Abed Hammoud, CEO of Renishaw Mayfield said, “This launch marks another important milestone for Renishaw in our endeavour to broaden the range of surgical solutions for our neuromate system. neurolocate will allow us to help surgeons further in providing optimal care for their patients by further simplifying the surgical procedure while maintaining surgical accuracy.”
For further information on neuromate, visit www.renishaw.com/neuromate
About Renishaw
Renishaw is one of the world's leading engineering and scientific technology companies, with expertise in precision measurement and healthcare. The company supplies products and services used in applications as diverse as jet engine and wind turbine manufacture, through to dentistry and brain surgery. It is also a world leader in the field of additive manufacturing (also referred to as 3D printing), where it is the only UK business that designs and makes industrial machines which ‘print' parts from metal powder.
The Renishaw Group currently has more than 70 offices in 32 countries, with around 4,000 employees, of which 2,600 people are employed within the UK. The majority of the company's R&D and manufacturing is carried out in the UK and for the year ended June 2014 Renishaw achieved sales of £355.5 million of which 93% was due to exports. The company's largest markets are the USA, China, Germany and Japan.
Help employers find you! Check out all the jobs and post your resume.
